Evidence map›Paper›PMID 41258073›Full record

ArticleExperimental & molecular medicine2025

RNA N

Shuang Lu, Xingyu Wei, Huan Zhu, Leyuan Li, Wenqian Zhang, Pei Du, Yaqin Yu, Meiling Zheng, Zhi Hu, Sujie Jia and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental & molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. The Role of NMedComm · 2026
    Review
  3. Elevated mBMC cancer · 2026
    Article
  4. mFrontiers in immunology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shuang Lu *Department of Dermatology, Human Key Laboratory of Medical Epigenomics, the Second Xiangya Hospital, Central South University, Changsha, China.
Xingyu Wei *Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.
Huan ZhuDepartment of Dermatology, Human Key Laboratory of Medical Epigenomics, the Second Xiangya Hospital, Central South University, Changsha, China.
Leyuan LiDepartment of Dermatology, Human Key Laboratory of Medical Epigenomics, the Second Xiangya Hospital, Central South University, Changsha, China.
Wenqian ZhangDepartment of Dermatology, Human Key Laboratory of Medical Epigenomics, the Second Xiangya Hospital, Central South University, Changsha, China.
Pei DuDepartment of Dermatology, Human Key Laboratory of Medical Epigenomics, the Second Xiangya Hospital, Central South University, Changsha, China.
Yaqin YuDepartment of Dermatology, Human Key Laboratory of Medical Epigenomics, the Second Xiangya Hospital, Central South University, Changsha, China.
Meiling ZhengHospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.
Zhi HuHospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.
Sujie JiaDepartment of Pharmacy, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.
Qianjin LuDepartment of Dermatology, Human Key Laboratory of Medical Epigenomics, the Second Xiangya Hospital, Central South University, Changsha, China. qianlu5860@pumcderm.cams.cn.ORCID http://orcid.org/0000-0002-1504-4896
Ming ZhaoDepartment of Dermatology, Human Key Laboratory of Medical Epigenomics, the Second Xiangya Hospital, Central South University, Changsha, China. zhaoming301@pumcderm.cams.cn.ORCID http://orcid.org/0000-0002-1320-1093

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B cell malfunction is implicated in the pathogenesis of systemic lupus erythematosus (SLE) through the release of proinflammatory cytokines and the production of autoreactive antibodies. RNA N

Indexed as

AdenosineCell DifferentiationInterferon Regulatory FactorsLupus Erythematosus, SystemicPlasma CellsRNA-Binding ProteinsAnimalsDisease Models, AnimalFemaleHumansInterferon Regulatory Factor-4MiceAdenosineInterferon Regulatory Factor-4Interferon Regulatory FactorsN-methyladenosineRNA-Binding ProteinsYTHDF1 protein, human

Identifiers

PMID41258073
PMCPMC12686027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.